Cardiovascular monitoring and diagnostics generally refers to continuous monitoring of heart activity, generally by electrocardiography, with assessment of the patient’s condition relative to their cardiac rhythm. Diagnosis and monitoring of cardiovascular disorders have become the need for the global healthcare industry in order to prevent the rapid rise in the deaths due to various cardiovascular disorders. Monitoring of the heart rate can be performed as part of electrocardiography, but it can also be measured conveniently with specific heart rate monitors. Globally rising aging population, incidence of cardiovascular diseases and growing awareness about the risks associated cardiovascular diseases primarily contribute towards the growth of global cardiovascular monitoring and diagnostic devices market.
The global cardiovascular monitoring and diagnostic devices market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).
The global cardiovascular monitoring and diagnostic devices market segmentation is based on device or product types (ECG systems, resting ECG systems, stress ECG systems, cardiovascular diagnostic catheters, event monitors, Holter monitors, implantable loop recorders, ECG management systems).
The global cardiovascular monitoring and diagnostic devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cardiovascular monitoring and diagnostic devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global cardiovascular monitoring and diagnostic devices market and included in this report are Boston Scientific Corporation, Covidien plc, FUKUDA DENSHI Co., Ltd., GE Healthcare, Johnson & Johnson, Medtronic, Inc, Nihon Kohden Corporation, Philips Healthcare, Siemens Healthcare, Sorin Group, Spacelabs Healthcare, St. Jude Medical, Inc and Welch Allyn, Inc.